CNT-2130

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameCNT-2130
Drug Alias NameCNT-2130CNT2130
ClassificationSmall molecules
Mechanisms of ActionSphingolipid delta(4)-desaturase DES1 inhibitors
TargetsSphingolipid delta(4)-desaturase DES1
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCentaurus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCentaurus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A